The exact mechanism of ANCA-related RPGN due to COVID-19 vaccine remains unknown, but it is hypothesized that an enhanced immune response after booster vaccination and the presence of HLA-DR+ monocytes could trigger the production of observed MPO- and PR3-ANCA autoantibodies [33,34,35]. This evidence concerns the gene MPO and rapidly progressive glomerulonephritis.